
Brian J. Gangle
Examiner (ID: 12421, Phone: (571)272-1181 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645 |
| Total Applications | 1198 |
| Issued Applications | 778 |
| Pending Applications | 134 |
| Abandoned Applications | 322 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19262781
[patent_doc_number] => 20240206476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => BIOLOGICAL INSECTICIDE FORMULATION, FREE OF CHEMICAL PRODUCTS, FOR INSECT PEST CONTROL IN PLANTS
[patent_app_type] => utility
[patent_app_number] => 18/576206
[patent_app_country] => US
[patent_app_date] => 2021-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3574
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18576206
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/576206 | BIOLOGICAL INSECTICIDE FORMULATION, FREE OF CHEMICAL PRODUCTS, FOR INSECT PEST CONTROL IN PLANTS | Sep 23, 2021 | Pending |
Array
(
[id] => 20348556
[patent_doc_number] => 20250345408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-11-13
[patent_title] => BCG VACCINATIONS FOR PREVENTION OF COVID-19 AND OTHER INFECTIOUS DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/027696
[patent_app_country] => US
[patent_app_date] => 2021-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5298
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18027696
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/027696 | BCG VACCINATIONS FOR PREVENTION OF COVID-19 AND OTHER INFECTIOUS DISEASES | Sep 22, 2021 | Pending |
Array
(
[id] => 17337421
[patent_doc_number] => 20220003752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => CELL-BASED METHOD FOR DETERMINING AN ACTIVITY OF BOTULINUM TOXIN
[patent_app_type] => utility
[patent_app_number] => 17/482035
[patent_app_country] => US
[patent_app_date] => 2021-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25652
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 220
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17482035
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/482035 | CELL-BASED METHOD FOR DETERMINING AN ACTIVITY OF BOTULINUM TOXIN | Sep 21, 2021 | Abandoned |
Array
(
[id] => 17334679
[patent_doc_number] => 20220001010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => ADJUVANTING SYSTEMS AND WATER-FREE VACCINE COMPOSITIONS COMPRISING A POLYI:C POLYNUCLEOTIDE ADJUVANT AND A LIPID-BASED ADJUVANT
[patent_app_type] => utility
[patent_app_number] => 17/480304
[patent_app_country] => US
[patent_app_date] => 2021-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34583
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17480304
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/480304 | ADJUVANTING SYSTEMS AND WATER-FREE VACCINE COMPOSITIONS COMPRISING A POLYI:C POLYNUCLEOTIDE ADJUVANT AND A LIPID-BASED ADJUVANT | Sep 20, 2021 | Abandoned |
Array
(
[id] => 19464461
[patent_doc_number] => 20240318130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => BACTERIAL STRAIN BELONGING TO THE GENUS CHRISTENSENELLA, AND COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/269878
[patent_app_country] => US
[patent_app_date] => 2021-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15639
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18269878
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/269878 | BACTERIAL STRAIN BELONGING TO THE GENUS CHRISTENSENELLA, AND COMPOSITIONS | Sep 15, 2021 | Pending |
Array
(
[id] => 17314541
[patent_doc_number] => 20210403589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => COMBINATION THERAPIES WITH ANTI CD40 ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 17/475592
[patent_app_country] => US
[patent_app_date] => 2021-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21817
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17475592
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/475592 | COMBINATION THERAPIES WITH ANTI CD40 ANTIBODIES | Sep 14, 2021 | Abandoned |
Array
(
[id] => 18707672
[patent_doc_number] => 20230330252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => CONJUGATE AND PHOTOIMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 18/044728
[patent_app_country] => US
[patent_app_date] => 2021-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12590
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044728
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/044728 | CONJUGATE AND PHOTOIMMUNOTHERAPY | Sep 6, 2021 | Pending |
Array
(
[id] => 18724415
[patent_doc_number] => 20230338574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => ANTIBODY-NANOPARTICLE COMPLEXES AND METHODS FOR MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/043722
[patent_app_country] => US
[patent_app_date] => 2021-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23045
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -53
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043722
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/043722 | ANTIBODY-NANOPARTICLE COMPLEXES AND METHODS FOR MAKING AND USING THE SAME | Aug 31, 2021 | Pending |
Array
(
[id] => 17482155
[patent_doc_number] => 20220089659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => MESOPHILIC ARGONAUTE SYSTEMS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/464635
[patent_app_country] => US
[patent_app_date] => 2021-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64209
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17464635
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/464635 | Mesophilic argonaute systems and uses thereof | Aug 31, 2021 | Issued |
Array
(
[id] => 18675139
[patent_doc_number] => 20230312725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => SIGNAL PEPTIDE FOR REDUCING END HETEROGENEITY OF HETEROLOGOUS POLYPEPTIDE
[patent_app_type] => utility
[patent_app_number] => 18/023301
[patent_app_country] => US
[patent_app_date] => 2021-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12924
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18023301
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/023301 | SIGNAL PEPTIDE FOR REDUCING END HETEROGENEITY OF HETEROLOGOUS POLYPEPTIDE | Aug 26, 2021 | Pending |
Array
(
[id] => 18673047
[patent_doc_number] => 20230310519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => USE OF ADLERCREUTZIA BACTERIA FOR THE TREATMENT OF INFLAMMATORY DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/022763
[patent_app_country] => US
[patent_app_date] => 2021-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10255
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18022763
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/022763 | USE OF ADLERCREUTZIA BACTERIA FOR THE TREATMENT OF INFLAMMATORY DISEASES | Aug 23, 2021 | Pending |
Array
(
[id] => 17349953
[patent_doc_number] => 11224571
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-18
[patent_title] => Oral dispersible vaccine comprising virosomes
[patent_app_type] => utility
[patent_app_number] => 17/409050
[patent_app_country] => US
[patent_app_date] => 2021-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 16793
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17409050
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/409050 | Oral dispersible vaccine comprising virosomes | Aug 22, 2021 | Issued |
Array
(
[id] => 18793955
[patent_doc_number] => 11827707
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-28
[patent_title] => Anti PD-L1 antibodies
[patent_app_type] => utility
[patent_app_number] => 17/399891
[patent_app_country] => US
[patent_app_date] => 2021-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 35
[patent_no_of_words] => 20272
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 198
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17399891
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/399891 | Anti PD-L1 antibodies | Aug 10, 2021 | Issued |
Array
(
[id] => 17719115
[patent_doc_number] => 20220211834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => METHODS AND COMPOSITIONS FOR INDUCING IMMUNE RESPONSES AGAINST CLOSTRIDIUM DIFFICILE
[patent_app_type] => utility
[patent_app_number] => 17/398610
[patent_app_country] => US
[patent_app_date] => 2021-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12297
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17398610
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/398610 | Methods and compositions for inducing immune responses against | Aug 9, 2021 | Issued |
Array
(
[id] => 17291007
[patent_doc_number] => 20210386846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => NOVEL METHODS FOR INDUCING AN IMMUNE RESPONSE
[patent_app_type] => utility
[patent_app_number] => 17/397379
[patent_app_country] => US
[patent_app_date] => 2021-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24692
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17397379
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/397379 | NOVEL METHODS FOR INDUCING AN IMMUNE RESPONSE | Aug 8, 2021 | Abandoned |
Array
(
[id] => 18647828
[patent_doc_number] => 20230293603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => RECOMBINANT BACTERIA FOR PRODUCTION OF D-LACTATE AND/OR L-LACTATE AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/019383
[patent_app_country] => US
[patent_app_date] => 2021-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22365
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -56
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18019383
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/019383 | RECOMBINANT BACTERIA FOR PRODUCTION OF D-LACTATE AND/OR L-LACTATE AND USES THEREOF | Aug 5, 2021 | Abandoned |
Array
(
[id] => 17334429
[patent_doc_number] => 20220000760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => COMPOSITIONS AND METHODS FOR PREVENTING, SLOWING, AND REVERSING SKIN AGING
[patent_app_type] => utility
[patent_app_number] => 17/390821
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3893
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17390821
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/390821 | COMPOSITIONS AND METHODS FOR PREVENTING, SLOWING, AND REVERSING SKIN AGING | Jul 29, 2021 | Abandoned |
Array
(
[id] => 18647824
[patent_doc_number] => 20230293599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => BACTERIAL COMPOSITIONS WITH ANTI-INFLAMMATORY ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 18/040402
[patent_app_country] => US
[patent_app_date] => 2021-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22147
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040402
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/040402 | BACTERIAL COMPOSITIONS WITH ANTI-INFLAMMATORY ACTIVITY | Jul 28, 2021 | Pending |
Array
(
[id] => 18565707
[patent_doc_number] => 20230256034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING AUTOIMMUNE AND ALLERGIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/006385
[patent_app_country] => US
[patent_app_date] => 2021-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22669
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -259
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18006385
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/006385 | METHODS AND COMPOSITIONS FOR TREATING AUTOIMMUNE AND ALLERGIC DISORDERS | Jul 21, 2021 | Pending |
Array
(
[id] => 18565705
[patent_doc_number] => 20230256032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => PREVOTELLA HISTICOLA STRAIN C AS AN ORAL THERAPY FOR INFLAMMATORY DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/005145
[patent_app_country] => US
[patent_app_date] => 2021-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59208
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -129
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18005145
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/005145 | PREVOTELLA HISTICOLA STRAIN C AS AN ORAL THERAPY FOR INFLAMMATORY DISEASES | Jul 19, 2021 | Pending |